Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-12-000002

CEO bought 10,000 shares at an average $0.52 ($5,155)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Babcock Dwight William CEO 2012-03-22 Purchase +4,900 $0.53 $2,585 168,161 D
Babcock Dwight William CEO 2012-03-22 Purchase +100 $0.50 $50 168,261 D
Babcock Dwight William CEO 2012-03-22 Purchase +1,000 $0.52 $520 169,261 D
Babcock Dwight William CEO 2012-03-20 Purchase +4,000 $0.50 $2,000 173,261 D
Open-market purchases · 10,000 sh · avg $0.52 · $5,155
Loading xslF345X03/primary_doc.xml…